0897.HK

Drug and healthcare products maker Wai Yuen Tong Medicine Holdings Ltd. (0897.HK) warned on Monday that it expects to report its profit plunged 87% year-on-year to HK$3 million ($390,000) or less in the six months through September, the first half of its fiscal year, from the HK$23.7 million a year earlier.

The company said its retail business was hit by weak consumer sentiment during the reporting period, resulting in a 7% drop in revenue and a corresponding decline in gross profit. Meanwhile, its net gain from property disposals also fell significantly, and a decrease in fair value gains of its investment properties further weighed on its profits. Those negative factors were partially offset by lower administrative expenses and financing costs, it added.

Wai Yuen Tong’s stock opened flat on Tuesday and closed at HK$0.45 by the midday break, with no change. The stock is up about 80% year-to-date.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Expansion into Middle East sends shares soaring, but Zhida's valuation looks steep

Middle East expansion charges up Zhida’s stock

Shares of the EV charger maker, whose backers include BYD, jumped nearly 10% after announcing its latest expansion plan Key Takeaways: Zhida plans to enter the Middle East, targeting Saudi…
51World faces IPO reality check

Earth Clone designer 51World faces IPO reality check

The maker of “digital twin” tools and simulations, including a plan for a virtual copy of the earth’s surface, is grappling with earnings pressure and rising competition Key Takeaways: The…